|
AT9283
A multi-targeted c-Abl, JAK2, Aurora A and B inhibitor
Product Overview
Product Name: AT9283
Alternate Name/Synonyms: 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
Description: A pan-Aurora kinase inhibitor (IC₅₀ = 3 nM for both Aurora A and B). AT9283 also potently inhibits several kinases including the JAK2 and 3 (IC₅₀’s 1.2 and 1.1 nM, respectively), c-Abl(IC₅₀ = 110 nM) and Abl/T315I (IC₅₀ = 4 nM).
Peptide Sequence: N/A
Appearance: Off-white solid
Formulation: N/A
CAS Number: 896466-04-9
Molecular Formula: C19H23N7O2
Molecular Weight: 381.43
Purity: ≥98% by HPLC
Solubility:DMSO (>70 mg/ml) or EtOH (>25 mg/ml)
Storage Temp.: -20 ̊C
Shipping Conditions: gel pack
Handling: Protect from light and air
SMILES: C1CC1NC(=O)NC2=CNNC2=C3N=C4C=CC(=CC4=N3)CN5CCOCC5
InChi: InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13,20,25H,2-3,5-8,11H2,(H2,21,24,27)/b18-17-
InChi Key: VRXXZJLHPWWXIX-ZCXUNETKSA-N
PubChem CID: 11696609
MDL Number: N/A
USAGE: For Research Use Only! Not For Use in Humans. |